TransMedics (TMDX) Other Accumulated Expenses (2018 - 2026)

TransMedics has reported Other Accumulated Expenses for 9 years, with the latest figure at $19.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses rose 42.93% year-over-year to $19.7 million; the trailing twelve-month figure through Mar 2026 stood at $19.7 million (up 42.93% YoY), and the FY2025 full-year result was $18.4 million, up 90.42% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $19.7 million, up from $18.4 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $19.7 million in Q1 2026, with the low at $2.7 million in Q1 2023.
• Average Other Accumulated Expenses over 5 years is $10.1 million, with a median of $10.4 million recorded in 2024.
• Year-over-year, Other Accumulated Expenses plunged 41.35% in 2023 and surged 391.46% in 2024.
• Tracing TMDX's Other Accumulated Expenses over 5 years: stood at $4.4 million in 2022, then soared by 169.56% to $11.8 million in 2023, then slipped by 18.08% to $9.6 million in 2024, then jumped by 90.42% to $18.4 million in 2025, then climbed by 7.27% to $19.7 million in 2026.
• The last three Other Accumulated Expenses figures came in at $19.7 million (Q1 2026), $18.4 million (Q4 2025), and $15.8 million (Q3 2025), per Business Quant data.

Peer Comparison